Eur Rev Med Pharmacol Sci 2016; 20 (22): 4766-4774

S100B in serum and saliva: a valid invasive or non-invasive biomarker in obstructive sleep apnea?

M. Traxdorf, O. Wendler, K. Tziridis, J. Bauer, C. Scherl

Department of Otorhinolaryngology, Head & Neck Surgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany. maximilian.traxdorf@uk-erlangen.de


OBJECTIVE:  The aim of this prospective study was to determine whether serum or saliva S100B could be established as an invasive or non-invasive biomarker of cerebrovascular stress due to chronic intermittent hypoxia in obstructive sleep apnea (OSA).

PATIENTS AND METHODS: S100B levels in serum and saliva were measured by an enzyme-linked immunosorbent assay (ELISA) in 40 patients with polysomnographically confirmed OSA (n=34) or ronchopathy (n=6) and 20 control subjects (n=20). We also investigated four healthy volunteers (n=4) to determine whether the S100B levels in serum and saliva are dependent on the time of day.

RESULTS: Serum S100B was significantly higher in OSA than in healthy control subjects (p=0.007), although it was not related to the severity of OSA and was independent of age, sex, and subjective daytime symptoms. Values of S100B in saliva showed a marked scatter, so there was no significant difference between the OSA group and controls (p=0.62). We did not find that S100B levels in either serum or saliva depended on the time of day (p=0.53; p=0.91).

CONCLUSIONS: Serum S100B allows us to discriminate healthy subjects from patients with OSA. However, it does not live up to its promise as a valid invasive predictor of OSA, since it does not correlate with the severity of the disease. Also, S100B in saliva is not suitable for use as a non-invasive biomarker to detect hypoxia-induced cerebrovascular stress in OSA. This finding prevents an S100B saliva-based assessment of risk or possible extent of structural brain damage, ruling out the possibility of non-invasive home monitoring of compliance and therapeutic efficacy in cases of OSA on treatment.

Free PDF Download

To cite this article

M. Traxdorf, O. Wendler, K. Tziridis, J. Bauer, C. Scherl
S100B in serum and saliva: a valid invasive or non-invasive biomarker in obstructive sleep apnea?

Eur Rev Med Pharmacol Sci
Year: 2016
Vol. 20 - N. 22
Pages: 4766-4774